LAFAYETTE GENERAL MEDICAL CENTER — History
CCN 190002 | 3-year financial timeline | COVID resilience: 31/100
🛡️ Public data only — no PHI permitted on this instance.
$480M
Latest Revenue (FY2022)
-1.3%
Revenue CAGR (3yr)
-16.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $492M | $475M | $480M | +1.1% | -1.3% |
| Operating Expenses | $482M | $511M | $559M | +9.5% | +7.7% |
| Operating Margin | 2.1% | -7.6% | -16.4% | -116.6% | +0.0% |
| Net Income | $10M | $-36M | $-79M | -119.1% | +0.0% |
| Licensed Beds | 390 | 387 | 390 | +0.8% | +0.0% |
| Total Patient Days | 109,138 | 115,282 | 104,834 | -9.1% | -2.0% |
| Medicare Day % | 35% | 31% | 28% | -8.1% | -10.1% |
| Medicaid Day % | 1% | 1% | 1% | -10.1% | -19.3% |
COVID Impact & Recovery
Resilience Score: 31/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -2.5% ($492M → $480M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-1.3%
This Hospital
+7.6%
State Avg
Latest Margin
-16.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $474M | -25.7% |
| FY2024 (proj) | $468M | -35.0% |
| FY2025 (proj) | $462M | -44.2% |